During the past decade, Szpital Powiatowy w Czeladzi conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Powiatowy w Czeladzi" #1 collaborator was "APCER Life Sciences" with 1 trials as a collaborator, "KCAS Bio" with 1 trials as a collaborator and "PharmaConsulting Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Szpital Powiatowy w Czeladzi" are "Alzheimer's Disease" (1 trials), "Central Neuropathic Pain" (1 trials) and "Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Szpital Powiatowy w Czeladzi" in a lesser frequency.

Most popular intervention types in "Szpital Powiatowy w Czeladzi" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ALZT-OP1a" (1 trials), "ALZT-OP1b" (1 trials), "AVP-923-20" (1 trials), "AVP-923-30" (1 trials) and "AVP-923-45" (1 trials). Other intervention names were less common.

The vast majority of trials in "Szpital Powiatowy w Czeladzi" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Szpital Powiatowy w Czeladzi". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Szpital Powiatowy w Czeladzi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Szpital Powiatowy w Czeladzi, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".